CareDx Inc (CDNA) reports a 21% revenue increase and raises 2025 guidance amid innovation and operational improvements.

CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ — a leading precision medicine company focused on the discovery, ...

CareDx (NASDAQ: CDNA) has been analyzed by 3 analysts in the last three months, revealing a diverse range of perspectives ...

Fintel reports that on November 6, 2025, BTIG maintained coverage of CareDx (NasdaqGM:CDNA) with a Buy recommendation.

CareDx (CDNA) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.14 per share a year ago. These figures are ...

AMD's next-gen CDNA 3 architecture will be the first exascale APU design, packing both CPU and GPU chiplets on the same package. AMD has promised an insane 5x or higher (AI) performance-per-watt ...

Most attempts to identify and isolate a novel cDNA result in the acquisition of clones that represent only a part of the mRNA's complete sequence. The ever-growing collections of sequenced genomes and ...

MyPrize Markets will allow users to participate in markets covering sports, politics, cryptocurrency, and other events, ...

Multiple intravenous injections of a cDNA library, derived from human melanoma cell lines and expressed using the highly immunogenic vector vesicular stomatitis virus (VSV), cured mice with ...

In addition to the Instinct MI325X AI Accelerator, AMD also updated its AMD Instinct roadmap and previewed the upcoming Instinct MI355X AI Accelerator at its Advance AI event held earlier. Based on ...